{
  "questionId": "NCLEX_NGN_Psych_NMS_Ordered_001",
  "itemType": "standalone",
  "questionType": "orderedResponse",
  "caseId": null,
  "question": {
    "stem": "The nurse is reviewing the client's electronic health record (EHR) before administering 0900 medications. Based on the provided information, what actions should the nurse take? Arrange the actions in the correct order of priority, from first to last.",
    "options": [
      {
        "id": "opt1",
        "label": "Withhold the scheduled 0900 dose of haloperidol."
      },
      {
        "id": "opt2",
        "label": "Apply supplemental oxygen via a non-rebreather mask."
      },
      {
        "id": "opt3",
        "label": "Initiate active cooling measures, such as applying a cooling blanket."
      },
      {
        "id": "opt4",
        "label": "Establish large-bore intravenous access and place the client on a cardiac monitor."
      },
      {
        "id": "opt5",
        "label": "Activate the facility's rapid response team (RRT)."
      }
    ]
  },
  "tabs": [
    {
      "id": "tab1",
      "label": "Nurses' Notes",
      "content": "A 45-year-old male client with a history of schizophrenia was admitted 2 days ago from a supported living facility for management of increasing agitation. \n\n**0800 Note:** \nClient found diaphoretic, minimally responsive to verbal stimuli. Appears extremely stiff when staff attempts repositioning. Unable to answer orientation questions, muttering incoherently. Drooling noted from the side of the mouth. Skin is hot and flushed to the touch."
    },
    {
      "id": "tab2",
      "label": "Vital Signs",
      "content": [
        {
          "time": "Yesterday 2100",
          "T": "37.2°C (99.0°F)",
          "HR": "88/min",
          "RR": "18/min",
          "BP": "130/84 mmHg",
          "SpO2": "98% on room air"
        },
        {
          "time": "Today 0400",
          "T": "37.8°C (100.0°F)",
          "HR": "102/min",
          "RR": "22/min",
          "BP": "145/90 mmHg",
          "SpO2": "96% on room air"
        },
        {
          "time": "Today 0815",
          "T": "40.1°C (104.2°F)",
          "HR": "135/min, regular",
          "RR": "28/min, shallow",
          "BP": "160/100 mmHg",
          "SpO2": "91% on room air"
        }
      ]
    },
    {
      "id": "tab3",
      "label": "Laboratory Results",
      "content": "Drawn at 0815, Stat Results:\n- **Creatine Kinase (CK):** 15,200 U/L (Reference: 30-200 U/L)\n- **WBC Count:** 18,500/mm³ (Reference: 4,500-11,000/mm³)\n- **Potassium:** 5.8 mEq/L (Reference: 3.5-5.0 mEq/L)\n- **Creatinine:** 1.9 mg/dL (Reference: 0.6-1.2 mg/dL)"
    },
    {
      "id": "tab4",
      "label": "Medication Administration Record (MAR)",
      "content": "Scheduled Medications:\n- Haloperidol 5 mg IM every 6 hours (Next dose due at 0900)\n- Benztropine 1 mg PO twice daily (Given at 0830)\n- Docusate Sodium 100 mg PO daily (Given at 0830)\n\nPRN Medications:\n- Lorazepam 1 mg PO every 8 hours PRN for agitation (Last given yesterday at 2200)"
    }
  ],
  "correctAnswer": [
    "opt2",
    "opt1",
    "opt5",
    "opt4",
    "opt3"
  ],
  "rationale": {
    "correct": "The client's presentation—hyperthermia, extreme muscle rigidity ('lead pipe' rigidity), altered mental status, and autonomic instability (tachycardia, tachypnea, labile BP)—combined with a markedly elevated creatine kinase (CK) is pathognomonic for Neuroleptic Malignant Syndrome (NMS), a life-threatening emergency caused by dopamine-blocking agents like haloperidol. NMS results from a sudden reduction in dopamine activity, leading to hypothalamic and autonomic dysfunction, and muscle rigidity due to impaired calcium reuptake in the sarcoplasmic reticulum. The nursing priorities must follow the sequence of addressing immediate life threats (Airway, Breathing, Circulation), stopping the offending agent, escalating care, and then managing the systemic complications.\n\n1.  **Apply supplemental oxygen:** The SpO2 of 91% with tachypnea indicates hypoxia, the most immediate threat to life. The high metabolic rate from fever and rigidity increases oxygen demand, making this the top priority (ABCs). Hypoxia can lead to cellular damage and organ failure if not corrected promptly.\n2.  **Withhold haloperidol:** This is the critical 'SAFETY STOP' action. Administering another dose of the causative agent would be catastrophic, worsening the dopamine blockade and accelerating the syndrome. Haloperidol blocks dopamine receptors in the brain, and in NMS, this blockade is excessive, leading to the syndrome's characteristic symptoms.\n3.  **Activate RRT:** NMS causes rapid deterioration. The nurse must immediately escalate care to bring a multidisciplinary team to the bedside for advanced management. Early intervention by a specialized team can significantly improve outcomes.\n4.  **Establish IV access and cardiac monitoring:** Hyperkalemia (5.8 mEq/L) from rhabdomyolysis poses a severe risk of fatal cardiac dysrhythmias. IV access is vital for fluid resuscitation to protect the kidneys and to administer emergency medications. Continuous cardiac monitoring is essential to detect and treat potentially lethal arrhythmias like ventricular tachycardia or fibrillation. Rhabdomyolysis occurs due to muscle breakdown, releasing intracellular contents like potassium and myoglobin into the bloodstream.\n5.  **Initiate active cooling:** The extreme hyperthermia (40.1°C) can cause brain damage and multi-organ failure. Cooling must be initiated promptly, but only after stabilizing oxygenation, stopping the cause, and calling for help. Hyperthermia in NMS is due to hypothalamic dysfunction and increased muscle activity, leading to a rapid rise in body temperature.",
    "incorrect": "Incorrect ordering of these actions can lead to client harm. Delaying oxygenation can lead to respiratory failure and cardiac arrest. Administering the haloperidol is a sentinel event and is absolutely contraindicated. Delaying the RRT call prevents timely, advanced intervention. While cooling and IV access are crucial, they do not take precedence over correcting hypoxia and stopping the progression of the syndrome.",
    "answerBreakdown": [
      {
        "label": "Apply supplemental oxygen via a non-rebreather mask.",
        "content": "Correctly placed as the **first** priority. The client's SpO2 is 91% with a respiratory rate of 28/min, indicating acute hypoxemia. This is a critical 'Breathing' issue in the ABCDE assessment and must be addressed immediately to prevent cardiovascular collapse and further neurological injury.",
        "isCorrect": true
      },
      {
        "label": "Withhold the scheduled 0900 dose of haloperidol.",
        "content": "Correctly placed as the **second** priority. This is the essential 'DON'T PROCEED' step. The client is exhibiting a severe adverse reaction to the antipsychotic. Administering more haloperidol would worsen the underlying pathophysiology of NMS. This action is a critical independent nursing judgment to prevent iatrogenic harm and must be done immediately after addressing the immediate threat to life (hypoxia).",
        "isCorrect": true
      },
      {
        "label": "Activate the facility's rapid response team (RRT).",
        "content": "Correctly placed as the **third** priority. After stabilizing immediate ABCs and ensuring no further harm is done (withholding the medication), the nurse must escalate care. NMS requires intensive, coordinated care that is beyond the scope of a single nurse. The RRT brings critical care expertise and resources to the bedside.",
        "isCorrect": true
      },
      {
        "label": "Establish large-bore intravenous access and place the client on a cardiac monitor.",
        "content": "Correctly placed as the **fourth** priority. This action prepares for managing the life-threatening complications of NMS. The hyperkalemia (5.8 mEq/L) requires urgent cardiac monitoring to detect arrhythmias. IV access is essential for aggressive fluid resuscitation to treat rhabdomyolysis-induced acute kidney injury (evidenced by Creatinine of 1.9) and for administering medications like dantrolene or bromocriptine.",
        "isCorrect": true
      },
      {
        "label": "Initiate active cooling measures, such as applying a cooling blanket.",
        "content": "Correctly placed as the **fifth** priority. While the hyperthermia is severe and dangerous, interventions to correct it follow the stabilization of ABCs, halting the causative agent, and calling for help. Cooling is a critical intervention but is less immediate than providing oxygen or preventing further medication-related harm.",
        "isCorrect": true
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Analyzing",
    "cjmmStep": "Take Actions",
    "nclexCategory": "Management of Care",
    "difficulty": 5,
    "topicTags": [
      "Neuroleptic Malignant Syndrome",
      "Antipsychotic Medications",
      "Adverse Drug Reaction",
      "Prioritization",
      "Safety Stop",
      "Clinical Judgment",
      "Rhabdomyolysis"
    ]
  },
  "sbar": {
    "situation": "At 0815, a 45-year-old male with schizophrenia, admitted for increasing agitation, is exhibiting signs of Neuroleptic Malignant Syndrome (NMS). He is diaphoretic, minimally responsive, and exhibits muscle rigidity. He is unable to answer orientation questions and is drooling.",
    "background": "The client was admitted two days ago from a supported living facility. He is receiving scheduled haloperidol 5mg IM every 6 hours (next dose due at 0900), benztropine 1mg PO twice daily (given at 0830), and docusate sodium 100mg PO daily (given at 0830). Lorazepam 1mg PO every 8 hours PRN for agitation (last given yesterday at 2200) is also prescribed.",
    "assessment": "At 0815, the client's vital signs are: T 40.1°C (104.2°F), HR 135/min, RR 28/min, BP 160/100 mmHg, SpO2 91% on room air. Lab results drawn at 0815 show: CK 15,200 U/L, WBC 18,500/mm³, Potassium 5.8 mEq/L, Creatinine 1.9 mg/dL.",
    "recommendation": "The client is exhibiting signs of Neuroleptic Malignant Syndrome (NMS). Immediate interventions are required, including applying supplemental oxygen via a non-rebreather mask, withholding the scheduled 0900 dose of haloperidol, activating the Rapid Response Team, establishing large-bore IV access and placing the client on a cardiac monitor, and initiating active cooling measures."
  },
  "clinicalPearls": [
    "Neuroleptic Malignant Syndrome (NMS) is a life-threatening emergency characterized by hyperthermia, muscle rigidity, altered mental status, and autonomic dysfunction, typically triggered by dopamine-blocking agents.",
    "Early recognition and intervention are crucial in managing NMS. Key actions include immediately discontinuing the offending medication, providing supportive care (ABCs), and considering specific treatments like dantrolene or bromocriptine.",
    "Rhabdomyolysis and subsequent hyperkalemia and acute kidney injury are common and potentially fatal complications of NMS, necessitating close monitoring of electrolytes, renal function, and cardiac rhythm. Aggressive fluid resuscitation is often required.",
    "Always prioritize airway, breathing, and circulation (ABCs) when managing a patient with suspected NMS. Hypoxia can rapidly lead to cardiovascular collapse.",
    "Elevated Creatine Kinase (CK) levels are a key diagnostic indicator of NMS and rhabdomyolysis, reflecting muscle damage. However, CK levels can also be elevated in other conditions, so clinical context is essential."
  ],
  "sentinelStatus": "healed_v2026_v8"
}